118 related articles for article (PubMed ID: 14565160)
1. SPARC affects glioma cell growth differently when grown on brain ECM proteins in vitro under standard versus reduced-serum stress conditions.
Vadlamuri SV; Media J; Sankey SS; Nakeff A; Divine G; Rempel SA
Neuro Oncol; 2003 Oct; 5(4):244-54. PubMed ID: 14565160
[TBL] [Abstract][Full Text] [Related]
2. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins.
Rempel SA; Golembieski WA; Fisher JL; Maile M; Nakeff A
J Neurooncol; 2001 Jun; 53(2):149-60. PubMed ID: 11716067
[TBL] [Abstract][Full Text] [Related]
3. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo.
Schultz C; Lemke N; Ge S; Golembieski WA; Rempel SA
Cancer Res; 2002 Nov; 62(21):6270-7. PubMed ID: 12414657
[TBL] [Abstract][Full Text] [Related]
4. cDNA array analysis of SPARC-modulated changes in glioma gene expression.
Golembieski WA; Rempel SA
J Neurooncol; 2002 Dec; 60(3):213-26. PubMed ID: 12510773
[TBL] [Abstract][Full Text] [Related]
5. A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC secretion correlates with decreased migration on vitronectin.
Menon PM; Gutierrez JA; Rempel SA
Int J Oncol; 2000 Oct; 17(4):683-93. PubMed ID: 10995878
[TBL] [Abstract][Full Text] [Related]
6. HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion.
Golembieski WA; Thomas SL; Schultz CR; Yunker CK; McClung HM; Lemke N; Cazacu S; Barker T; Sage EH; Brodie C; Rempel SA
Glia; 2008 Aug; 56(10):1061-75. PubMed ID: 18442089
[TBL] [Abstract][Full Text] [Related]
7. Secretion of SPARC by endothelial cells transformed by polyoma middle T oncogene inhibits the growth of normal endothelial cells in vitro.
Sage EH
Biochem Cell Biol; 1992 Jul; 70(7):579-92. PubMed ID: 1449724
[TBL] [Abstract][Full Text] [Related]
8. Secreted protein acidic and rich in cysteine is a matrix scavenger chaperone.
Chlenski A; Guerrero LJ; Salwen HR; Yang Q; Tian Y; Morales La Madrid A; Mirzoeva S; Bouyer PG; Xu D; Walker M; Cohn SL
PLoS One; 2011; 6(9):e23880. PubMed ID: 21949685
[TBL] [Abstract][Full Text] [Related]
9. Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition.
Dhanesuan N; Sharp JA; Blick T; Price JT; Thompson EW
Breast Cancer Res Treat; 2002 Sep; 75(1):73-85. PubMed ID: 12500936
[TBL] [Abstract][Full Text] [Related]
10. Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation.
Shi Q; Bao S; Maxwell JA; Reese ED; Friedman HS; Bigner DD; Wang XF; Rich JN
J Biol Chem; 2004 Dec; 279(50):52200-9. PubMed ID: 15469933
[TBL] [Abstract][Full Text] [Related]
11. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
Shi Q; Bao S; Song L; Wu Q; Bigner DD; Hjelmeland AB; Rich JN
Oncogene; 2007 Jun; 26(28):4084-94. PubMed ID: 17213807
[TBL] [Abstract][Full Text] [Related]
12. Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models.
Park CR; Jo JH; Song MG; Park JY; Kim YH; Youn H; Paek SH; Chung JK; Jeong JM; Lee YS; Kang KW
Theranostics; 2019; 9(24):7447-7457. PubMed ID: 31695779
[TBL] [Abstract][Full Text] [Related]
13. SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.
McClung HM; Thomas SL; Osenkowski P; Toth M; Menon P; Raz A; Fridman R; Rempel SA
Neurosci Lett; 2007 May; 419(2):172-7. PubMed ID: 17490812
[TBL] [Abstract][Full Text] [Related]
14. SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells.
Tumbarello DA; Andrews MR; Brenton JD
PLoS One; 2016; 11(9):e0162698. PubMed ID: 27622658
[TBL] [Abstract][Full Text] [Related]
15. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
Basu A; Rodeck U; Prendergast GC; Howe CC
Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of secreted protein acidic and rich in cysteine (SPARC) expression diminishes radiosensitivity of glioma cells.
Liu H; Zhang H; Jiang X; Ma Y; Xu Y; Feng S; Liu F
Cancer Biother Radiopharm; 2011 Dec; 26(6):705-15. PubMed ID: 22145659
[TBL] [Abstract][Full Text] [Related]
17. Increased SPARC expression promotes U87 glioblastoma invasion in vitro.
Golembieski WA; Ge S; Nelson K; Mikkelsen T; Rempel SA
Int J Dev Neurosci; 1999; 17(5-6):463-72. PubMed ID: 10571408
[TBL] [Abstract][Full Text] [Related]
18. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
[TBL] [Abstract][Full Text] [Related]
19. Proteolysis of the matricellular protein hevin by matrix metalloproteinase-3 produces a SPARC-like fragment (SLF) associated with neovasculature in a murine glioma model.
Weaver M; Workman G; Schultz CR; Lemke N; Rempel SA; Sage EH
J Cell Biochem; 2011 Nov; 112(11):3093-102. PubMed ID: 21688302
[TBL] [Abstract][Full Text] [Related]
20. Production and purification of recombinant human SPARC.
Workman G; Bradshaw AD
Methods Cell Biol; 2018; 143():335-345. PubMed ID: 29310786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]